Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Stomach Cancer Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Stomach Cancer Treatment Market, by Type, 2019-2029 (USD Billion)
1.2.3. Stomach Cancer Treatment Market, by End-users, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Stomach Cancer Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Stomach Cancer Treatment Market Dynamics
3.1. Stomach Cancer Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of stomach or gastric cancer
3.1.1.2. Rising expenditure on healthcare
3.1.2. Market Challenges
3.1.2.1. Lack of reimbursement for currently approved targeted therapies
3.1.2.2. High cost of drugs and cancer treatment
3.1.3. Market Opportunities
3.1.3.1. Growing availability of advanced healthcare facilities
3.1.3.2. Introduction of various novel therapies for metastatic stomach cancer
Chapter 4. Global Stomach Cancer Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Stomach Cancer Treatment Market, by Type
6.1. Market Snapshot
6.2. Global Stomach Cancer Treatment Market by Type, Performance - Potential Analysis
6.3. Global Stomach Cancer Treatment Market Estimates & Forecasts by Type, 2019-2029 (USD Billion)
6.4. Stomach Cancer Treatment Market, Sub Segment Analysis
6.4.1. Chemotherapy
6.4.2. Radiotherapy
6.4.3. Immunotherapy
6.4.4. Targeted Drug Therapy
6.4.5. Surgery
Chapter 7. Global Stomach Cancer Treatment Market, by End-users
7.1. Market Snapshot
7.2. Global Stomach Cancer Treatment Market by End-users, Performance - Potential Analysis
7.3. Global Stomach Cancer Treatment Market Estimates & Forecasts by End-users, 2019-2029 (USD Billion)
7.4. Stomach Cancer Treatment Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Specialty & Retail Pharmacies
7.4.3. Others
Chapter 8. Global Stomach Cancer Treatment Market, Regional Analysis
8.1. Stomach Cancer Treatment Market, Regional Market Snapshot
8.2. North America Stomach Cancer Treatment Market
8.2.1. U.S. Stomach Cancer Treatment Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. End-users breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Stomach Cancer Treatment Market
8.3. Europe Stomach Cancer Treatment Market Snapshot
8.3.1. U.K. Stomach Cancer Treatment Market
8.3.2. Germany Stomach Cancer Treatment Market
8.3.3. France Stomach Cancer Treatment Market
8.3.4. Spain Stomach Cancer Treatment Market
8.3.5. Italy Stomach Cancer Treatment Market
8.3.6. Rest of Europe Stomach Cancer Treatment Market
8.4. Asia-Pacific Stomach Cancer Treatment Market Snapshot
8.4.1. China Stomach Cancer Treatment Market
8.4.2. India Stomach Cancer Treatment Market
8.4.3. Japan Stomach Cancer Treatment Market
8.4.4. Australia Stomach Cancer Treatment Market
8.4.5. South Korea Stomach Cancer Treatment Market
8.4.6. Rest of Asia Pacific Stomach Cancer Treatment Market
8.5. Latin America Stomach Cancer Treatment Market Snapshot
8.5.1. Brazil Stomach Cancer Treatment Market
8.5.2. Mexico Stomach Cancer Treatment Market
8.6. Rest of The World Stomach Cancer Treatment Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Novartis AG
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Pfizer, Inc.
9.2.3. Mylan N.V.
9.2.4. F. Hoffmann La Roche Ltd.
9.2.5. Eli Lilly And Company
9.2.6. Merck & Co., Inc.
9.2.7. Teva Pharmaceutical Industries Ltd.
9.2.8. Celltrion Healthcare Co., Ltd.
9.2.9. Samsung Bioepis
9.2.10. Bristol Myers Squibb Company
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption